Your browser doesn't support javascript.
loading
Novel CD19 chimeric antigen receptor T cells manufactured next-day for acute lymphoblastic leukemia.
Zhang, Cheng; He, Jiaping; Liu, Li; Wang, Jishi; Wang, Sanbin; Liu, Ligen; Ge, Jian; Gao, Lei; Gao, Li; Kong, Peiyan; Liu, Yao; Liu, Jia; Han, Yu; Zhang, Yongliang; Sun, Zhe; Ye, Xun; Yin, Wenjie; Sersch, Martina; Shen, Lianjun; Cao, Wei William; Zhang, Xi.
Afiliación
  • Zhang C; Medical Center of Hematology, Xinqiao Hospital, State Key Laboratory of Trauma, Burn and Combined Injury, Army Medical University, Chongqing, P. R. China.
  • He J; Gracell Biotechnologies Ltd, Shanghai, P. R. China.
  • Liu L; Department of Hematology, Tangdu Hospital, Air Force Medical University, Xi'an, Shaanxi, P. R. China.
  • Wang J; Department of Hematology, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, P. R. China.
  • Wang S; Department of Hematology, 920th Hospital of Joint Logistics Support Force, Kunming, Yunnan, P. R. China.
  • Liu L; Department of Hematology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.
  • Ge J; Department of Hematology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, P. R. China.
  • Gao L; Medical Center of Hematology, Xinqiao Hospital, State Key Laboratory of Trauma, Burn and Combined Injury, Army Medical University, Chongqing, P. R. China.
  • Gao L; Medical Center of Hematology, Xinqiao Hospital, State Key Laboratory of Trauma, Burn and Combined Injury, Army Medical University, Chongqing, P. R. China.
  • Kong P; Medical Center of Hematology, Xinqiao Hospital, State Key Laboratory of Trauma, Burn and Combined Injury, Army Medical University, Chongqing, P. R. China.
  • Liu Y; Medical Center of Hematology, Xinqiao Hospital, State Key Laboratory of Trauma, Burn and Combined Injury, Army Medical University, Chongqing, P. R. China.
  • Liu J; Gracell Biotechnologies Ltd, Shanghai, P. R. China.
  • Han Y; Gracell Biotechnologies Ltd, Shanghai, P. R. China.
  • Zhang Y; Gracell Biotechnologies Ltd, Shanghai, P. R. China.
  • Sun Z; Gracell Biotechnologies Ltd, Shanghai, P. R. China.
  • Ye X; Gracell Biotechnologies Ltd, Shanghai, P. R. China.
  • Yin W; Gracell Biotechnologies Ltd, Shanghai, P. R. China.
  • Sersch M; Gracell Biotechnologies Ltd, Shanghai, P. R. China.
  • Shen L; Gracell Biotechnologies Ltd, Shanghai, P. R. China. lj.shen@gracellbio.com.
  • Cao WW; Gracell Biotechnologies Ltd, Shanghai, P. R. China.
  • Zhang X; Medical Center of Hematology, Xinqiao Hospital, State Key Laboratory of Trauma, Burn and Combined Injury, Army Medical University, Chongqing, P. R. China. zhangxxi@sina.com.
Blood Cancer J ; 12(6): 96, 2022 06 24.
Article en En | MEDLINE | ID: mdl-35750687
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Linfoma de Células B / Leucemia-Linfoma Linfoblástico de Células Precursoras / Receptores Quiméricos de Antígenos Límite: Humans Idioma: En Revista: Blood Cancer J Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Linfoma de Células B / Leucemia-Linfoma Linfoblástico de Células Precursoras / Receptores Quiméricos de Antígenos Límite: Humans Idioma: En Revista: Blood Cancer J Año: 2022 Tipo del documento: Article